19 research outputs found
EVALUATION OF FDA AND EMA MODELS' CUT-OFF VALUES FOR CYP3A INHIBITION PREDICTION: A COLLABORATIVE EFFORT AMONG ACADEMIC, REGULATORY AGENCIES, AND INNOVATION AND QUALITY CONSORTIUM (IQC) PHARMACEUTICAL SCIENTISTS.
No full text
Evaluation of Various Static In vitro-In vivo Extrapolation Models for Risk Assessment of CYP3A Inhibition Potential of an Investigational Drug
No full text
Application of Receiver Operating Characteristic Analysis to Refine the Prediction of Potential Digoxin Drug Interactions
No full textInvestigation of combined CYP3A4 inductive/inhibitory properties by studying statin interactions: a model study with the renin inhibitor ACT-178882
No full textReliability and Extension of Quantitative Prediction of CYP3A4-Mediated Drug Interactions Based on Clinical Data
No full text
Soybean greatly reduces valproic acid plasma concentrations: A food–drug interaction study
No full text
